Davis C E, Carpenter J L, Trevino S, Koch J, Ognibene A J
Department of Medicine, Brooke Army Medical Center, Fort Sam Houston, Texas.
Diagn Microbiol Infect Dis. 1987 Nov;8(3):149-55. doi: 10.1016/0732-8893(87)90165-9.
In vitro agar dilution susceptibility studies were performed utilizing 20 isolates (24 against rifamycin) of Mycobacterium avium complex against several antimicrobial agents not routinely tested in the mycobacteriology laboratory. Thirteen strains were susceptible to gentamicin at 4 micrograms/ml, 20 to amikacin at 8 micrograms/ml, 18 to streptomycin at 8 micrograms/ml, 20 to kanamycin at 8 micrograms/ml, 20 to trimethoprim/sulfamethoxazole at 2 micrograms/ml, 12 to sulfisoxazole at 10 micrograms/ml, 14 to rifabutin at 1 microgram/ml. No activity was found with penicillin G, cephapirin, moxalactam, vancomycin, clindamycin, erythromycin, trimethoprim, or minocycline. This data suggests a potential use of trimethoprim/sulfamethoxazole, sulfisoxazole, amikacin, gentamicin, and kanamycin in the treatment of infections caused by this group of organisms.
利用20株鸟分枝杆菌复合体菌株(针对利福霉素的有24株)对几种在分枝杆菌实验室未常规检测的抗菌药物进行了体外琼脂稀释药敏研究。13株菌株对4微克/毫升的庆大霉素敏感,20株对8微克/毫升的阿米卡星敏感,18株对8微克/毫升的链霉素敏感,20株对8微克/毫升的卡那霉素敏感,20株对2微克/毫升的甲氧苄啶/磺胺甲恶唑敏感,12株对10微克/毫升的磺胺异恶唑敏感,14株对1微克/毫升的利福布汀敏感。青霉素G、头孢匹林、莫拉卡星、万古霉素、克林霉素、红霉素、甲氧苄啶或米诺环素均无活性。该数据表明甲氧苄啶/磺胺甲恶唑、磺胺异恶唑、阿米卡星、庆大霉素和卡那霉素在治疗由该组生物体引起的感染方面具有潜在用途。